.jpg)
Johnson & Johnson
Corporate VC · (United States)
Sign up free to access full profile and submit your pitch.
About
Johnson & Johnson Innovation – JJDC, Inc. (JJDC) is the strategic venture capital arm of Johnson & Johnson. JJDC pursues opportunities to solve critical healthcare needs. Our portfolio companies benefit from the full global capabilities of Johnson & Johnson as we collaborate to drive innovation. JJDC finds transformative ideas and helps them mature into real solutions for today’s patients. Guided by a clear, consistent investment strategy aligned with scientific goals, JJDC works hand-in-hand with partners to navigate the path to creating breakthrough health innovations. We invest across sectors—pharmaceuticals, medical devices and consumer healthcare—and at all stages, from seed-level startups to Series B and beyond. All of our portfolio companies receive the same unwavering commitment. We take a long-term approach, deploying the full capabilities of the Johnson & Johnson family of companies, including discovery, clinical development, regulatory affairs, manufacturing and commercialization. Our team includes leaders in the healthcare and technology communities, many with deep R&D experience. This gives us the ability to understand our partners and provide the help they need. Every opportunity is unique, with tailored roles and terms that provide the best path to success.
Visit website ↗Investment Criteria
Sign up free to see full investment criteria and submit your pitch.
Co-Investors of Johnson & Johnson
Other investors that have backed the same portfolio companies as Johnson & Johnson. Expand any entry to see the shared portfolio companies.
- 14 shared
Shared portfolio companies
- 10 shared
Shared portfolio companies
- ApoGen Biotechnologies, Inc.
- Fate Therapeutics, Inc.
- Genetix Biotherapeutics, Inc.
- HealthTech Services Corporation
- Lyell Immunopharma, Inc.
- Magnolia Neurosciences Corporation
- Proniras Corporation
- Rapport Therapeutics, Inc.
- ROME Therapeutics, Inc.
- SonoThera, Inc.
- 10 shared
Shared portfolio companies
- Accent Therapeutics, Inc.
- Cala Health, Inc.
- Carbon, Inc.
- Chrome Holding Co.
- Mestag Therapeutics Ltd
- Perceive Biotherapeutics, Inc.
- Perceive Pharma, Inc.
- Ribon Therapeutics, Inc.
- ROME Therapeutics, Inc.
- Verana Health, Inc.
- 9 shared
Shared portfolio companies
- 7 shared
Shared portfolio companies
- 7 shared
Shared portfolio companies
- 6 shared
Shared portfolio companies






